Device Trial Radar · NCT05336877
Aveir VR Coverage With Evidence Development Post-Approval Study
Last checked: Nov 20, 2026Latest source record: Oct 19, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Active, not recruiting
Enrollment
8,744
Planned (sponsor's estimate)
Start
Jun 21, 2022
Primary completion
Jan 1, 2028
Study completion Jan 1, 2028
Sponsor
- Lead sponsor
- Abbott Medical DevicesPublic (ABT)
- Sponsor type
- Industry
- First posted
- Apr 20, 2022
Design
- Study type
- Observational
- FDA-regulated device
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this coverage with evidence development (CED) study is to evaluate complications and long-term health outcomes of the single-chamber Aveir Single-Chamber Leadless Pacemaker device (Aveir VR LP).
Conditions
- Cardiac Pacemaker
- Arrythmia
- Bradycardia
Interventions
Aveir VR Leadless Pacemaker SystemDevice
This study will utilize real-world data from patients implanted with the Aveir VR Leadless Pacemaker System. No device intervention is required in this study.
Single-Chamber Transvenous PacemakerDevice
This study will utilize real-world data from patients implanted with a single-chamber transvenous pacemaker as a comparator to the Aveir VR LP system study arm. No device intervention is required in this study.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Number of Subjects with Acute Device-Related ComplicationsTime frame: 30 days
- Number of Subjects Alive after 2 YearsTime frame: 2 years
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Abbott
Sylmar, California
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.